These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 23102987)
1. Effectiveness of a Protective Environment implementation for cancer patients with chemotherapy-induced neutropenia on fever and mortality incidence. Stoll P; Silla LM; Cola CM; Splitt BI; Moreira LB Am J Infect Control; 2013 Apr; 41(4):357-9. PubMed ID: 23102987 [TBL] [Abstract][Full Text] [Related]
2. Footwear exchange has no influence on the incidence of febrile neutropenia in patients undergoing chemotherapy for hematologic malignancies. Sugahara H; Mizuki M; Matsumae S; Nabetani Y; Kikuchi M; Kanakura Y Infect Control Hosp Epidemiol; 2004 Jan; 25(1):51-4. PubMed ID: 14756220 [TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies. Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671 [TBL] [Abstract][Full Text] [Related]
4. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia. Ghalaut PS; Sen R; Dixit G J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972 [TBL] [Abstract][Full Text] [Related]
5. Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: a prospective observational safety study. Slobbe L; Waal Lv; Jongman LR; Lugtenburg PJ; Rijnders BJ Eur J Cancer; 2009 Nov; 45(16):2810-7. PubMed ID: 19647995 [TBL] [Abstract][Full Text] [Related]
6. [Fever profile of febrile neutropenia in patients treated with cancer chemotherapy for hematological malignancies]. Tamai Y; Imataki O; Kawakami K Gan To Kagaku Ryoho; 2010 May; 37(5):859-62. PubMed ID: 20495316 [TBL] [Abstract][Full Text] [Related]
8. Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort study. Offidani M; Corvatta L; Malerba L; Marconi M; Bichisecchi E; Cecchini S; Manso E; Principi T; Gasparini S; Leoni P Cancer; 2004 Aug; 101(3):567-77. PubMed ID: 15274070 [TBL] [Abstract][Full Text] [Related]
9. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Castagnola E; Fontana V; Caviglia I; Caruso S; Faraci M; Fioredda F; Garrè ML; Moroni C; Conte M; Losurdo G; Scuderi F; Bandettini R; Tomà P; Viscoli C; Haupt R Clin Infect Dis; 2007 Nov; 45(10):1296-304. PubMed ID: 17968824 [TBL] [Abstract][Full Text] [Related]
10. [Diagnostic procedures and management of Fever in pediatric cancer patients]. Laws HJ; Ammann RA; Lehrnbecher T Klin Padiatr; 2005 Nov; 217 Suppl 1():S9-16. PubMed ID: 16288350 [TBL] [Abstract][Full Text] [Related]
11. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group. Tamura K Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies]. Delarive P; Baumgartner JD; Glauser MP; Cometta A Schweiz Med Wochenschr; 2000 Dec; 130(48):1837-44. PubMed ID: 11132527 [TBL] [Abstract][Full Text] [Related]
13. [Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration]. Karthaus M; Südhoff T; Fenchel K; Egerer G; Kämpfe D; Ritter J; Franke A; Heil G; Peters G; Jürgens H Wien Med Wochenschr; 1998; 148(21):481-7. PubMed ID: 10048176 [TBL] [Abstract][Full Text] [Related]
14. The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease. Park Y; Kim DS; Park SJ; Seo HY; Lee SR; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS Leuk Res; 2010 Mar; 34(3):294-300. PubMed ID: 19762083 [TBL] [Abstract][Full Text] [Related]
15. [Changes in the epidemiology of infections in patients with febrile neutropenia]. Karthaus M; Carratala J Wien Med Wochenschr; 2001; 151(3-4):47-52. PubMed ID: 11789419 [TBL] [Abstract][Full Text] [Related]
16. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. Bucaneve G; Micozzi A; Menichetti F; Martino P; Dionisi MS; Martinelli G; Allione B; D'Antonio D; Buelli M; Nosari AM; Cilloni D; Zuffa E; Cantaffa R; Specchia G; Amadori S; Fabbiano F; Deliliers GL; Lauria F; Foà R; Del Favero A; N Engl J Med; 2005 Sep; 353(10):977-87. PubMed ID: 16148283 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of itraconazole as empirical antifungal therapy in febrile neutropenic patients with hematologic malignancies: an open-lable, multicenter, observational trial in a Chinese cohort. Cheng S; Zhou JF; Zou P; Huang XJ; Jin J; Shen ZX Chin Med J (Engl); 2011 Nov; 124(22):3670-5. PubMed ID: 22340222 [TBL] [Abstract][Full Text] [Related]